Taysha Gene Therapies, Inc. (TSHA)
6.39
+0.12
(+1.91%)
USD |
NASDAQ |
Apr 30, 16:00
6.375
-0.02
(-0.23%)
After-Hours: 20:00
Taysha Gene Therapies Total Liabilities (Quarterly) : 236.79M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 156.03M |
| Praxis Precision Medicines, Inc. | 59.79M |
| Aveanna Healthcare Holdings, Inc. | 1.831B |
| Palisade Bio, Inc. | 4.964M |
| Structure Therapeutics, Inc. | 67.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 483.73M |
| Shareholders Equity (Quarterly) | 246.94M |
| Debt to Equity Ratio | 0.2856 |
| Current Ratio | 12.22 |
| Net Debt Paydown Yield | -0.10% |